Skip to search formSkip to main contentSkip to account menu

strontium ranelate

Known as: 5-(Bis(Carboxymethyl)Amino)-2-Carboxy-4-Cyano-3-Thiopheneacetic Acid Strontium Salt (1:2) 
A substance that is being studied in the treatment of osteoporosis in postmenopausal women. Strontium ranelate helps new bone tissue to grow and… 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

Bone Density Conservation AgentsThiophenes

Narrower (2)

S 12911protelos

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Nanostrontium ranelate incorporated injectable hydrogel enhanced matrix production supporting chondrogenesis in vitro.
An injectable hydrogel, with the advantage of adaptability to defect sites, patient compliance, controlled flowability and high… 
Review
2014
Review
2014
An OA phenotype may obtain major benefit from bone-acting agents.
2011
2011
The status of strontium in biological apatites: an XANES/EXAFS investigation.
Osteoporosis represents a major public health problem through its association with fragility fractures. The public health burden… 
Highly Cited
2011
Highly Cited
2011
Activation of FGF Receptors is a new Mechanism by which Strontium Ranelate Induces Osteoblastic Cell Growth
Background/Aims: Strontium ranelate (SrRan) is an anti-osteoporotic treatment that reduces the risk of vertebral and hip… 
2010
2010
Incidence of Venous Thromboembolism in Users of Strontium Ranelate
AbstractBackground: Strontium ranelate is indicated for the treatment of postmeno-pausal osteoporosis. An association between… 
2010
2010
Effects of Alendronate and Strontium Ranelate on Cancellous and Cortical Bone Mass in Glucocorticoid-Treated Adult Rats
We studied the effects of alendronate (Aln) and strontium ranelate (SrR) administration on cancellous and cortical bone in… 
Review
2010
Review
2010
Strontium ranelate in osteoporosis and beyond: identifying molecular targets in bone cell biology.
Osteoporosis is characterized by reduced bone mass and deterioration of bone microarchitecture, resulting in bone fragility and… 
2009
2009
Bone imaging and chronic kidney disease: will high-resolution peripheral tomography improve bone evaluation and therapeutic management?
Bone damage because of chronic kidney disease (CKD) represents a daily challenge for nephrologists. The impact of CKD on bone… 
2008
2008
Strontium ranelate-induced toxic epidermal necrolysis in a patient with post-menopausal osteoporosis
Osteoporosis is a major worldwide health problem associated with enormous costs, morbidity and mortality. Strontium ranelate is a… 
Review
2008
Review
2008
Bone-forming agents in the management of osteoporosis.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)